Scientific Program

4th Annual Meeting of EUTROC: Translational Research in Ovarian Cancer – from Concept to Clinical Practice

Download the agenda here

CME Accreditation

The EUTROC meeting has been awarded the ESMO Label and accredited by the ESMO ECWG with: 10, cat. 1 ESMO-MORA points

Abstract submission

The meeting provides the opportunity to submit an abstract. Abstracts are subject to acceptance by the scientific

committee. Once accepted, abstracts will be published as E-poster on the EUTROC website. Additionally, the

presenting author of a selected proffered paper is invited to present the abstract at the meeting.

Abstract submission deadline: September 10, 2012

Topics for which abstracts can be submitted should be related to translational research in ovarian cancer.

Please click here for the abstract submission guidelines.

Please note that abstract submission is part of the registration process. Therefore, abstract submission

cannot be done without registering for meeting attendance. Per your preference submit your abstract

as an oral presentation or an E-poster. The Abstract Committee will decide which abstracts will be

accepted and also which abstracts are selected for an oral presentation. Should your abstract not be

accepted by the abstract review committee, then you are entitled to get your registration fee refunded.

Venue and Accommodation

Recommended Hotel

Hotel bookings shall be made on delegates’ own behalf independent to meeting registration.

Information about recommended hotels and special rates can be found here:

Recommended hotel

Fees & Registration

This educational program is intended for basic scientists, gynecologists, medical oncologists, and other healthcare

professionals in active clinical practice interested in and/or involved in the management of patients with

ovarian cancer.

The target number of attendees is 175.

Official Language

Official language of the meeting is English.

Contact

CONGRESS SECRETARIAT

E: jane.williams@clatterbridgecc.nhs.uk

Sponsors

EUTROC wishes to express their appreciation to:

Bronze sponsor

Supporter

Endorser

Scientific Program

Pitfalls and Solutions in Ovarian Cancer

Download the agenda here

Faculty

CME Accreditation

The EUTROC meeting 9-11 December 2011, Berlin , Germany, Pitfalls and Solutions in Ovarian Cancer

has been awarded the ESMO Label and accredited by the ESMO ECWG with: 14, cat. 1 ESMO-MORA points

Official Language

Official language of the meeting is English.

Venues and Accommodation

Meeting Venues

Railway Station

Berlin Hauptbahnhof (1.00 km to Campus Charité Mitte)

Airports

Flughafen Berlin Tegel (10.00 km)

Public Transportation to Campus Charité Mitte

Take bus TXL to station ‘Berlin Hauptbahnhof’ and change to bus 147 (direction Ostbahnhof).

Step out station ‘Campus Charité Mitte’.  

Duration: 30 min

Taxi

A taxi to the center of Berlin costs about €20.00 (day rate). Taxi stand is outside the airport.

Flughafen Berlin Schönefeld (25.00 km)

Public Transportation to Campus Charité Mitte

Take bus SXF (direction Sűdkreuz) and change at Sűdkreuz to S-Bahn line S2 (direction Bernau).

Step out Friedrichstraβe and take bus 147 (direction Hauptbahnhof) until station ‘Campus Charité Mitte’.

Duration: 55 min

Taxi

A taxi to the center of Berlin costs about €50.00 (day rate). Taxi stand is outside the airport.

Recommended Hotel

Hotel bookings shall be made on delegates’ own behalf independent to meeting registration.

Information about recommended hotels and special rates can be found here:

Recommended hotels

Fees and Registration

After receipt of your registration you will receive a confirmation. The target number of attendees is 100-150.

Payment

Payments can only be done by credit card.

Registration Fees

Cancellation policy registration fee

Cancellation fees will apply according to the following schedule:

Between September 1 – November 15: 50% of the costs will be charged

After November 15: 100% of the costs will be charged

For registration fees to be refunded, a written notice of cancellation must be received at EUTROC@trmoncology.com

no later than above mentioned dates 17:00 GMT +1. The amount of registration fees remitted,

will be refunded after the congress. Substitutions are accepted with written notification only.

EUTROC does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants

in the rare event that this program should be cancelled for any reason. Every effort will be made to give reasonable

notice in the event of cancellation of the program.

Bronze sponsors

EUTROC / ENTRIGO Joint Symposium at ESGO 17

Program

Sunday, September 11, 2011, 14:00 – 16:00

Chairs: Martin Widschwendter, UK / Jalid Sehouli, Germany

14:00 – 14:30 ENTRIGO – THE FIRST TRANS-EUROPEAN INITIATIVE IN TRANSLATIONAL RESEARCH IN WOMEN’S CANCERS Martin Widschwendter, UK

14:30 – 15:00 TRANSLATIONAL RESEARCH IN ENDOMETRIAL CANCERHelga Salvesen, Norway

15:00 – 15:30 OPTIONS AND LIMITS OF PREDICTIVE MARKERS IN GYNAECOLOGICAL ONCOLOGY Jalid Sehouli, Germany

15:30 – 16:00 MECHANISMS OF CHEMOTHERAPY RESISTANCE IN OVARIAN CANCER Hani Gabra, UK

Translational Research in Ovarian Cancer
European Scientific Meeting 2011

Program

Saturday, March 5, 2011, 08:00 – 13:00

08:00 – 08:30 Registration and Introduction Chairs: R. Zeillinger/D. Huntsman

08:30 – 08:40 Welcome Antonio Gonzalez / A. Poveda, GEICO

08:40 – 09:00 Introduction John Green, Liverpool

09:00 – 09:20 New insights in ovarian cancer etiology I. Meinhold-Heerlein, Berlin

09:20 – 09:40 Circulating Tumor DNA Xiao Yan Zhong, Basel

09:40 – 10:00 Circulating Tumor Cells B. Brandt, Hamburg

10:00 – 10:20 Discussion and summary Hani Gabra, London

10:20 – 11:00 Coffee/refreshments

11:00 – 13:00 Chairs: H. Gabra/ J. Sehouli

11:00 – 11:20 FDG PET as a predictor of response in gynaecological cancer clinical trials D. Slosman, Geneva

11:20 – 12:00 Integrating histopathology and molecular biomarkers: the 2011 classification of EOC D. Huntsman, Canada

12:00 – 12:20 New markers for early detection of ovarian cancer R. Zeillinger, Vienna

12:20 – 12:40 New concepts for drug development M. Costi, Modena

12:40 – 12:50 Summary J. Green, Liverpool

12:50 – 13:00 Closing remarks J. Sehouli, Berlin

13:00 – 13:30 Lunch

13:30 – 15:00 Bioinformatics in translational research workshopTBC separate registration required

Registration

For registration details: http://www.liv.ac.uk/cancer-cpd

For further information please contact j.a.green@liverpool.ac.uk

Sponsors

PERSONALIZED OVARIAN CANCER MANAGEMENT: HOPE OR HYPE?

Program

Saturday, October 23, 2010, 10:30 – 12:00 Hall B

10:30-10:40 Personalization and translation: What is EUTROC and why do we need it now
 Jalid Sehouli, Germany

10:40-10:55 Biomolecular insights in ovarian cancer: Information for personalization Michael Birrer, USA

10:55-11:10 Personalized medicine in clinical practice now: histological subtypes and clinical platinum resistance in ovarian cancer John Green, UK

11:10-11:25 Personalizing the reversal of treatment failure: strategies for targeting platinum resistance Hani Gabra, UK

11:25-11:40 Building technology into clinical trials – tools to improve our current and future projects Bob Brown, UK

11:40-11:50 EUTROC: Ongoing studies for a european dimension
 Franca Esposito, Italy and Robert Zeillinger, Austria

11:50-12:00 Summary: Addressing unmet needs by collaborative pan-european translational research Hani Gabra, UK

Program

19.09.2010

Social dinner

20.09.2010

08:00-10:00 Closed Meeting

10:00-17:30 Open Session

10:00-10:30 Description of the main EUTROC aims. What have been already achieved
10:30-12:00 On-going studies
12:00-13:00 Biological repositories of EUTROC centers and their potential future use.
13:00-14:00 Lunch
14:00-15:30 EU applications
15:30-16:00 Coffee break
16:00-17:00 Educational strategies
17:00-17:30 Conclusions